PART 01: Executive summary • Highlights PART 02: Scope of the report • Market overview • Top-vendor offerings PART 03: Market research methodology • Research methodology • Economic indicators PART 04: Introduction • Key market highlights • Invasive method • Non-invasive method PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global hemoglobin testing equipment market • Global hemoglobin testing reagents and consumables market PART 07: Market segmentation by technology • Chromatography • Immunoassay • Other PART 08: Market segmentation by end-user • Laboratories • Hospitals • Research centers PART 09: Geographical segmentation • Hemoglobin testing market in Americas • Reimbursement by Medicare in US • Hemoglobin testing market in EMEA • Hemoglobin testing market in APAC PART 10: Market drivers • Increasing incidence of diabetes and popularity of HbA1c tests • Favorable reimbursement of hemoglobin testing • Development and launch of novel hemoglobin testing devices PART 11: Impact of drivers PART 12: Market challenges • High cost and maintenance of hemoglobin testing • Stringent regulatory issues • Threat of substitute products PART 13: Impact of drivers and challenges PART 14: Market trends • Shift from centralized laboratory to POCT • Increased mergers and acquisition (M&A) • Direct-to-consumer testing PART 15: Vendor landscape • Competitive scenario PART 16: Key vendor profiles • Abbott Diagnostics • Alere • Danaher • EKF Diagnostics Holdings • Roche Diagnostics • Other prominent vendors PART 17: Appendix • List of abbreviations PART 18: Explore Technavio List of Exhibits Exhibit 01: Product offerings Exhibit 02: Types of hemoglobin testing methods Exhibit 03: Global hemoglobin testing market 2015-2020 ($ billions) Exhibit 04: Five forces analysis Exhibit 05: Global hemoglobin testing market segmentation based on product Exhibit 06: Global hemoglobin testing market segmentation based on product 2015 Exhibit 07: Global hemoglobin testing market segmentation based on product 2020 Exhibit 08: Global hemoglobin testing equipment market 2015 Exhibit 09: Global hemoglobin testing equipment market 2020 Exhibit 10: Global hemoglobin testing equipment market 2015-2020 ($ millions) Exhibit 11: Global laboratory testing market 2015-2020 ($ millions) Exhibit 12: Global POCT equipment market 2015-2020 ($ millions) Exhibit 13: Global hemoglobin testing reagent and consumables market 2015-2020 ($ billions) Exhibit 14: Segmentation of global hemoglobin testing market by product Exhibit 15: Segmentation of global hemoglobin testing market by product ($ millions) Exhibit 16: Segmentation of global hemoglobin testing market by technology 2015 Exhibit 17: Segmentation of global hemoglobin testing market by end-user 2015 Exhibit 18: Segmentation of global hemoglobin testing market by geography 2015 Exhibit 19: Segmentation of global hemoglobin testing market by geography 2020 Exhibit 20: Hemoglobinin testing market in Americas 2015-2020 ($ millions) Exhibit 21: Selected laboratory service with national limitation amount (NLA) provided by Medicare Exhibit 22: Estimation of few diseases in US Exhibit 23: Hemoglobin testing market in EMEA 2015-2020 ($ millions) Exhibit 24: Hemoglobin testing market in APAC 2015-2020 ($ millions) Exhibit 25: Segmentation of global hemoglobin testing market by geography Exhibit 26: Segmentation of global hemoglobin testing market by geography ($ millions) Exhibit 27: Impact of drivers Exhibit 28: Impact of drivers and challenges Exhibit 29: Abbott Diagnostics: Key takeaways Exhibit 30: Alere: Business segmentation by revenue 2014 Exhibit 31: Alere: Cardiometabolic division revenue and YoY growth rate 2012-2014 ($ millions) Exhibit 32: Alere: Key takeaways Exhibit 33: Danaher: Key takeaways Exhibit 34: EKF Diagnostics: Business segmentation by revenue 2014 Exhibit 35: EKF Diagnostics: Business segmentation by revenue 2013 and 2014 ($ millions) Exhibit 36: EKF Diagnostics Holdings: Key takeaways Exhibit 37: Roche Diagnostics: Business segmentation by revenue 2015 Exhibit 38: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2015 Exhibit 39: Roche Diagnostics: Diabetes care - geographical segmentation by revenue 2014 and 2015 ($ millions) Exhibit 40: Roche Diagnostics: Diabetes care - YoY revenue and growth rate ($ billions) Exhibit 41: Roche Diagnostics: Key takeaways

Abbott Diagnostics, Alere, Danaher, EKF Diagnostics Holdings, Roche Diagnostics, ACON Laboratories, ARKRAY, Bayer Medical Care, Bio-Rad Laboratories, Daiichi Biotech, DiaSys Diagnostic Systems, Diazyme Laboratories, Epinex Diagnostics, Erba Diagnostics, Fisher Scientific, GREEN CROSS MEDIS, HORIBA, HUMAN Gesellschaft für Biochemica und Diagnostica, Masimo, Mindray Medical International, OrSense, PTS Diagnostics, Randox Laboratories, Sebia, Siemens Healthcare, Sysmex, TaiDoc Technology, Tosoh Bioscience, Trinity Biotech, Una Health.